100%(8)8 out of 8 people found this document helpful
This preview shows page 1 - 3 out of 6 pages.
Running head: DIABETES AND DRUG TREATMENTS1Diabetes and Drug TreatmentsDana ProtomastroWalden UniversityAdvanced PharmacologyN6521April 3, 2019
DIABETES AND DRUG TREATMENTS2Diabetes and Drug TreatmentsDiabetes Mellitus (DM) is a chronic metabolic disease which according to the American Diabetes Association (ADA) affects 25.8 million people in the United States (Grossman & Mattson Porth, 2014). It is characterized by hyperglycemia or high blood sugar which is due to alterations in insulin production, resistance or both (Laureate Education, 2012). The purpose of this paper is to explain the difference between types of diabetes including type 1, type 2, gestational, and juvenile diabetes. The proper preparation and administration of metformin in treatment of Type 2 diabetes will be reviewed. Dietary considerations related to treatment will be discussed. Finally, short-term and long-term impact of type 2 diabetes on patients including effects of drugs treatments will be explainedType 1 DiabetesType 1 diabetes is due to a destruction beta cells of the pancreas. Destruction is due to anautoimmune process. This leads to an insufficient amount of insulin. These patients become completely deficient of insulin and are insulin dependent. Insulin is required to convert glucose for use by the cells of the body (American Diabetes Association, 2012). In its absence, glucose levels remain high.It was formerly referred to as juvenile diabetes. But contrary to popular belief it can occur at any age. Currently there are more adults suffering from the disease than children (American Diabetes Association, 2012). Age is a factor in that Type I DM onset occurs in individuals under the age of 30 years (Hammer & McPhee, 2014). It is considered juvenile diabetes when it manifests before the age of 18. It has been noted that there is a high incidence of juvenile diabetes in Alaska. This is thought to be due to environmental factors such as how we metabolize carbohydrates and the amount of vitamin D exposure (Barrell, 2017).